A study at the University of Toronto tested the accuracy of Viz ANEURYSM using 528 CTAs with 674 aneurysms broadly distributed across the cerebral vascular territories, encompassing anterior and ...

When given to mice in a model of vascular dementia, this drug promoted repair of brain tissue and recovery of memory and gait functions.

Cerebral vascular malformations (CVMs), including cerebral arteriovenous malformations (AVMs) and cavernous malformations (CCMs), have long posed challenges due to their complex origins and severe ...

The reduced blood supply starves brain cells of nutrients and over time they become damaged and die. Symptoms of vascular dementia include loss of energy, lack of concentration and poor memory.

Pre-eclampsia (PE), a serious hypertensive disorder that affects approximately 3–8% of pregnant women, is known to have long-lasting effects on the maternal vascular system.

Functional analysis revealed the overlap of genetic risks of all-cause dementia with neurodegeneration, vascular risk factors such as hypertension and diabetes, and cerebral small vessel disease.

Reduced cerebral blood flow is an early manifestation of dementia, and vascular risk factors such as hypertension, diabetes, atherosclerosis and Alzheimer’s disease are associated with reduced ...

UCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.

FDA has approved Viz ANEURYSM, designed to ensure cerebral aneurysms patients are captured and the system-wide aneurysm workflow is standardized.